Quantification of binary polymorphic mixtures of ranitidine hydrochloride using NIR spectroscopy

Vibrational Spectroscopy

Volumn 41, Issue 2, 2006, Pages 225-231

  McGoverin, Cushla M ^a   Ho, Louise C H ^a   Zeitler, J Axel ^a   Strachan, Clare J ^a   Gordon, Keith C ^a   Rades, Thomas ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Near infrared spectroscopy; Pharmaceuticals; Polymorphism; Ranitidine hydrochloride

Indexed keywords

DRUG PRODUCTS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; RAMAN SPECTROSCOPY; X RAY POWDER DIFFRACTION;

NEAR-INFRARED SPECTROSCOPY; POLYMORPHISM; RANITIDINE HYDROCHLORIDE; VIBRATIONAL SPECTROSCOPY;

BINARY MIXTURES;

EID: 33746873752     PISSN: 09242031     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vibspec.2006.04.026     Document Type: Article

References (18)

1. Brittain H.G. Physical Characterisation of Pharmaceutical Solid (1995), Marcel Dekker, New York pp. 59-91
2. Brittain H.G. Polymorphism in Pharamceutical Solids (2000), Marcel Dekker, New York
3. Brittain H.G. J. Pharm. Sci. 86 (1997) 205
4. Luner P.E., Majuru S., Seyer J.J., and Kemper M.S. Pharm. Dev. Tech. 5 (2000) 231
5. Patel A.D., Luner P.E., and Kemper M.S. Int. J. Pharm. 206 (2000) 63
6. Forster A., Gordon K., Schmierer D., Soper N., Wu V., and Rades T. Int. J. Vib. Spectr. 2 (1998) (Section 2)
7. Mirmehrabi M., Rohani S., Murthy K.S.K., and Radatus B. J. Cryst. Grow 260 (2004) 517
8. Mirmehrabi M., Rohani S., Murthy K.S.K., and Radatus B. Int. J. Pharm. 282 (2004) 73
9. Bernstein J. Polymorphism in Molecular Crystals (2002), Oxford University Press, Oxford pp. 298-301
10. Blanco M., Coello J., Iturriaga H., Maspoch S., and Pezuela C.D.L. Analyst 123 (1998) 135R
11. Bugay D.E. Adv. Drug Deliver. Res. 48 (2001) 43
12. Stephenson G.A., Forbes R.A., and Reutzel-Edens S.M. Adv. Drug Deliver. Res. 48 (2001) 67
13. Beebe K.R., Pell R.J., and Seaholtz M.B. Chemometrics: A Practical Guide (1998), John Wiley & Sons, New York pp. 278-335
14. Wold S., Sjöström M., and Eriksson L. Chem. Intel. Lab. Syst. 58 (2001) 109
15. Sertsou G., Kustrin S.A., and Rades T. Int. J. Vibtr. Spec. 5 (1999) (Section 3)
16. Kustrin S.A., Rades T., Wu V., Saville D., and Tucker I.G. J. Pharm. Biomed. Anal. 25 (2001) 741
17. Pratiwi D., Fawcett J.P., Gordon K.C., and Rades T. Eur. J. Pharm. Biopharm. 54 (2002) 337
18. The European Agency for the Evaluation of Medicinal Products, February 2003. Note for Guidance, EMEA/CVMP/961/01, CPMP/QWP/3309/01.